选择性氧化基作为可降解和生物相容的血静止剂,用于不受控制的出血和伤口愈合
Ruochen Ding1, Zhan Shu1, Jian Yang1
1Systems Engineering Institute, Academy of Military Sciences, Tianjin 300161, China.
International journal of biological macromolecules
|February 12, 2025
概括
氧化基 (OCT) 提供了一种新的静血材料,保留了有益的乙基. 这种生物相容和生物降解剂在与血液接触时迅速凝结,有效控制出血并促进伤口愈合.
科学领域:
- 生物材料科学 生物材料科学
- 聚合物化学 聚合物化学
- 血液静止研究 血液静止研究
背景情况:
- (CT) 是一种丰富的生物聚合物,具有静血潜力,但溶解性有限.
- 传统的基于基的血静止剂需要脱乙烯化 (基) 或苛刻的加工条件.
- 与酸盐中的氨基基组相比,酸盐中的乙烯基组对于高级血静,生物相容性和伤口愈合至关重要.
研究的目的:
- 从基直接开发一种新的静血剂,保留其乙基.
- 研究氧化基 (OCT) 的血静效能,生物相容性和生物降解性.
- 建立一种简单的方法来生产有效的基基血静止剂.
主要方法:
- 基经过了TEMPO介导的选择性氧化,从C6初级基基团转化为碳基基团,产生氧化基 (OCT).
- 合成和表征了具有不同碳酸盐含量的OCT.
- 在伤害模型中评估了静血性能,并与商业化素 (CeloxTM) 相比较.
- 进行了生物相容性和生物降解性评估.
主要成果:
- 与原生基相比,氧化基 (OCT) 具有显著增强的水友性.
- 在与血液接触时,OCT迅速形成凝,促进有效的血液静止.
- 在经过测试的伤害模型中,OCT-24显示出卓越的静血性能,生物相容性和生物降解性.
- 海洋国家和地区防止了组织粘附,并有效促进了伤口愈合.
结论:
- 通过TEMPO介导的氧化提供了一条直接而有效的途径,从基中产生有效的静血材料.
- 氧化基 (OCT) 是基托在静血应用中的一个有希望的替代品,它保留了有益的乙基.
- 基于OCT的血静止剂为管理大量出血和改善伤口愈合结果提供了可行的解决方案.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
601
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
601
01:05Introduction to Hemostasis
5.1K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.1K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
4.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.9K